DUBLIN, July 9, 2024 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Samantha Pearce, Senior Vice President (SVP), Europe and International, has been promoted to Chief ...
Jazz Pharmaceuticals JAZZ reported second-quarter results highlighted by total revenue of $957 million, representing a 3% increase from the prior-year period. The strong patient uptake of Xywav (the ...
Jazz Pharmaceuticals JAZZ reported healthy first-quarter results highlighted by total revenue of $893 million, representing a 10% increase from the prior-year period thanks to the company’s ...
Get more of a good thing! Our weekly newsletter highlights our top stories, our special offers, and upcoming jazz events near you. Tap the share button (the square icon with the up arrow) in the tab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results